Implementation of a Combination Intervention for Sustainable Blood Pressure Control

Hypertension Clinical Trial

— IMPACT-BP  

Official title:

Implementation of a Combination Intervention for Sustainable Blood Pressure Control in KwaZulu-Natal, South Africa (IMPACT-BP)

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT05492955
• Other study ID #: 2021P003469
• Status: Recruiting
• Phase: N/A
• Start date: November 30, 2022
• Est. completion date: April 30, 2025

Study information

• Verified date: April 2024
• Source: Brigham and Women's Hospital
• Contact: Shafika Abrahams-Gessel, AB, MS, DRPH
• Phone: 6174324385
• Email: sabraham[@]hsph.harvard.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This is a randomized clinical trial intended to identify the optimal strategy of blood pressure management in rural South Africa using Community Health Workers (CHWs) in conjunction with in-home BP monitoring among adults.

Description:

We will conduct a trial using CHWs in conjunction with in-home BP monitoring among 774 adults ≥ 18 years old residing in uMkhanyakude District in northern KwaZulu-Natal in an area that is served by a CHW. Eligible participants will be recruited from prior community-based hypertension screening programs, CHW-led hypertension screening activities, and/or from trial clinics where they are accessing care. Consenting participants will be randomized to one of the three study arms of hypertension care (258 participants per arm): 1) clinic-based standard of care model (SOC); 2) community health worker-based blood pressure monitoring model (CHW); 3) and enhanced community health worker-based model, including mobile health blood pressure monitoring model (eCHW+). Independent of clinical care, all participants will be seen at enrollment and at 6 months for BP monitoring and data collection by study nurses for outcome assessments. The primary effectiveness outcome will be assessed in an intention-to-treat analysis and defined as the change in systolic blood pressure (SBP) 6 months after enrollment. The secondary effectiveness outcome will be the proportion of participants with controlled blood pressure, as defined by an SBP <140 mmHg and a diastolic BP (DBP) <90 mmHg 6 months after enrollment.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 774
• Est. completion date: April 30, 2025
• Est. primary completion date: April 30, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Age greater than 18 years old

• Residing in uMkhanyakude District in northern KwaZulu-Natal in an area that is served by a CHW.

• Elevated blood pressure (blood pressure > 140/90 mmHg) on two measurements.

Exclusion Criteria:

• Pregnant or breast-feeding women.

• Severe, symptomatic hypertension with a measured blood pressure > 180/110 mmHg.

• Known, advanced chronic kidney disease. GFR < 60 ml/min/1.73 m2.

• Current use of at least 3 different anti-hypertensive therapies at full dose.

• Planning to move within the next 24 months.

Related Conditions & MeSH terms

• Hypertension

Intervention

Behavioral:
• Community Health Worker Care Model
Participants will be given a digital BP Cuff and a standardized training on its operation, and assigned a CHW from their local Community Health Team. The participant will be instructed to take 6-10 measurements BP per week and record them in a logbook. CHWs will return to participant homes every 2-4 weeks to collect BP measurements and enter them into a data collection system, assess for symptoms, and discuss treatment adherence and lifestyle recommendations. BP readings will be brought by the CHW to their assigned nursing supervisors at their local clinic, who will initiate and tailor medications based on a standardized clinical decision support algorithm, based on SA DoH hypertension control guidelines. All treatment decisions will be made by the nursing supervisors. Participants will either obtain medication(s) at the pharmacy or, as possible, have them delivered by a CHW.
• Enhanced Community Health Worker-based with Mobile Health Blood Pressure Monitoring Model
Participants in this arm will also be given a BP Cuff, (but with cellular network capability, such that BP data can be directly transmitted to trial server), given training on its operation, and assigned a CHW from their local Community Health Team. The participant will be instructed to take 6-10 measurements BP per week, which will be automatically uploaded onto the server to be made available by the nurse supervisors. CHWs will return to participant homes every 2-4 weeks to ensure functionality of the devices and transmission, collect BP measurements if the system is not functional, assess for symptoms, and discuss treatment adherence and lifestyle recommendations. Nursing supervisors at the clinic will use the remotely collected BP data to initiate and tailor medications based on the same standardized clinical decision support (CDS) algorithm, based on SA DoH hypertension control guidelines. All treatment decisions will be made by the nursing supervisors.
• Standard of Care Model
Participants in the SOC arm will be referred to their clinic for active care as per standard clinical protocols. All care will be provided at the clinic. Routine care consists of regular visits to the clinic until BP is under control (<140/90 mmHg) and then at 6 monthly intervals. BP measurements to guide management decisions will be made at the clinic using standard clinic equipment. Symptoms related to hypertension and/or medications will be assessed at each visit. Medications available will include medications on the South African Essential Drug list and which are available in the pharmacy. Prescriptions are picked up at the clinic pharmacy by patients as per routine protocol at the clinics. CHWs may also conduct monitoring as guided by clinical guidelines and as advised by their clinical supervisors during the study period to assess for adherence and provide education.

Locations

Country	Name	City	State
South Africa	Africa Health Research Institute (AHRI)	Mtubatuba	KwaZulu-Natal

Sponsors (1)

Lead Sponsor	Collaborator
Brigham and Women's Hospital

Country where clinical trial is conducted

South Africa, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Other	Adverse events (safety)	Number of adverse and severe adverse events	6 months
Primary	Mean systolic blood pressure change	Absolute change in systolic blood pressure (SBP) between baseline and 6 months after enrollment.	6 months
Secondary	Achievement of blood pressure control	Blood pressure control, defined as a BP <140/90 6 months after enrollment	6 months